Problem
Although reported to be less of a problem with Methimazole (Tapazole) than with Propylthiouracil (PTU), patients on antithyroid drugs are at risk for the development of the adverse event of agranulocytosis. Understanding the pharmacotherapeutic and adverse effects, which laborder sets would the APN routinely monitor for patients on Tapazole?